Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010, Article ID 727194, 14 pages
http://dx.doi.org/10.1155/2010/727194
Research Article

Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α

1NHEERL Toxicogenomics Core, US EPA, Research Triangle Park, NC 27711, USA
2Department of Pharmacology, Physiology and Therapeutics, University of North Dakota, School of Medicine, 501 N. Columbia Road, Grand Forks, ND 58203-2817, USA
3Syngenta Central Toxicology Laboratory, Alderley Park, Cheshire SK104TJ, UK
4Integrated Systems Toxicology Division, National Health and Environmental Effects Research Lab , US Environmental Protection Agency, Research Triangle Park, NC 27711, USA

Received 14 June 2010; Revised 13 October 2010; Accepted 1 November 2010

Academic Editor: Christopher Lau

Copyright © 2010 Hongzu Ren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Corton, S. P. Anderson, and A. Stauber, “Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators,” Annual Review of Pharmacology and Toxicology, vol. 40, pp. 491–518, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Klaunig, M. A. Babich, K. P. Baetcke et al., “PPARα agonist-induced rodent tumors: modes of action and human relevance,” Critical Reviews in Toxicology, vol. 33, no. 6, pp. 655–780, 2003. View at Google Scholar · View at Scopus
  3. J. M. Peters, R. C. Cattley, and F. J. Gonzalez, “Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643,” Carcinogenesis, vol. 18, no. 11, pp. 2029–2033, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Peters, T. Aoyama, R. C. Cattley, U. Nobumitsu, T. Hashimoto, and F. J. Gonzalez, “Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver,” Carcinogenesis, vol. 19, no. 11, pp. 1989–1994, 1998. View at Google Scholar · View at Scopus
  5. T. Hays, I. Rusyn, A. M. Burns et al., “Role of peroxisome proliferator-activated receptor-α (PPARα) in bezafibrate-induced hepatocarcinogenesis and cholestasis,” Carcinogenesis, vol. 26, no. 1, pp. 219–227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Shamovsky and E. Nudler, “New insights into the mechanism of heat shock response activation,” Cellular and Molecular Life Sciences, vol. 65, no. 6, pp. 855–861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Pirkkala, P. Nykänen, and L. Sistonen, “Roles of the heat shock transcription factors in regulation of the heat shock response and beyond,” FASEB Journal, vol. 15, no. 7, pp. 1118–1131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Christians and I. J. Benjamin, “Heat shock response: lessons from mouse knockouts,” Handbook of Experimental Pharmacology, no. 172, pp. 139–152, 2006. View at Google Scholar · View at Scopus
  9. A. M. Slavotinek and L. G. Biesecker, “Unfolding the role of chaperones and chaperonins in human disease,” Trends in Genetics, vol. 17, no. 9, pp. 528–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Åkerfelt, D. Trouillet, V. Mezger, and L. Sistonen, “Heat shock factors at a crossroad between stress and development,” Annals of the New York Academy of Sciences, vol. 1113, pp. 15–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Arya, M. Mallik, and S. C. Lakhotia, “Heat shock genes—integrating cell survival and death,” Journal of Biosciences, vol. 32, no. 3, pp. 595–610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Goldberg, “Protein degradation and protection against misfolded or damaged proteins,” Nature, vol. 426, no. 6968, pp. 895–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Meiners, D. Heyken, A. Weller et al., “Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes,” Journal of Biological Chemistry, vol. 278, no. 24, pp. 21517–21525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Corton and H. M. Brown-Borg, “Peroxisome proliferator-activated receptor γ coactivator 1 in caloric restriction and other models of longevity,” Journals of Gerontology A, vol. 60, no. 12, pp. 1494–1509, 2005. View at Google Scholar · View at Scopus
  15. C. Chen, G. E. Hennig, H. E. Whiteley, J. C. Corton, and J. E. Manautou, “Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure,” Toxicological Sciences, vol. 57, no. 2, pp. 338–344, 2000. View at Google Scholar · View at Scopus
  16. S. P. Anderson, P. Howroyd, J. Liu et al., “The transcriptional response to a peroxisome proliferator-activated receptor α agonist includes increased expression of proteome maintenance genes,” Journal of Biological Chemistry, vol. 279, no. 50, pp. 52390–52398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Corton, U. Apte, S. P. Anderson et al., “Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors,” Journal of Biological Chemistry, vol. 279, no. 44, pp. 46204–46212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Portilla, G. Dai, J. M. Peters, F. J. Gonzalez, M. D. Crew, and A. D. Proia, “Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure,” American Journal of Physiology, vol. 278, no. 4, pp. F667–F675, 2000. View at Google Scholar · View at Scopus
  19. A. Sivarajah, P. K. Chatterjee, Y. Hattori et al., “Agonists of peroxisome-proliferator activated receptor-α (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat,” Medical Science Monitor, vol. 8, no. 12, pp. BR532–BR539, 2002. View at Google Scholar · View at Scopus
  20. S. S. T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the α isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar · View at Scopus
  21. R. A. Jolly, K. M. Goldstein, T. Wei et al., “Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants,” Physiological Genomics, vol. 22, pp. 346–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. Martin, R. J. Brennan, W. Hu et al., “Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity,” Toxicological Sciences, vol. 97, no. 2, pp. 595–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. M. Sanderson, P. J. de Groot, G. J. E. J. Hooiveld et al., “Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics,” PLos One, vol. 3, no. 2, Article ID e1681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. Rosen, J. S. Lee, H. Ren et al., “Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPARα and CAR,” Toxicological Sciences, vol. 103, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. LI. Q. Fan, J. Coley, R. T. Miller, R. C. Cattley, and J. C. Corton, “Opposing mechanisms of NADPH-cytochrome P450 oxidoreductase regulation by peroxisome proliferators,” Biochemical Pharmacology, vol. 65, no. 6, pp. 949–959, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Corton, LI. Q. Fan, S. Brown et al., “Down-regulation of cytochrome P450 2C family members and positive acute- phase response gene expression by peroxisome proliferator chemicals,” Molecular Pharmacology, vol. 54, no. 3, pp. 463–473, 1998. View at Google Scholar · View at Scopus
  27. C. L. Wilson and C. J. Miller, “Simpleaffy: a bioConductor package for affymetrix quality control and data analysis,” Bioinformatics, vol. 21, no. 18, pp. 3683–3685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ellinger-Ziegelbauer, B. Stuart, B. Wahle, W. Bomann, and H. J. Ahr, “Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver,” Mutation Research, vol. 575, no. 1-2, pp. 61–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Nelson, V. Bhaskaran, W. R. Foster, and L. D. Lehman-McKeeman, “p53-independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16α-carbonitrile,” Toxicological Sciences, vol. 94, no. 2, pp. 272–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. A. Currie, V. Bombail, J. D. Oliver et al., “Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate,” Toxicological Sciences, vol. 86, no. 2, pp. 453–469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Vallanat, S. P. Anderson, H. M. Brown-Borg et al., “Analysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha),” BMC Genomics, vol. 11, p. 16, 2010. View at Publisher · View at Google Scholar
  32. M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert, “Peroxisome proliferators do not activate the transcription factors AP-1, early growth response-1, or heat shock factors 1 and 2 in rats or hamsters,” Toxicological Sciences, vol. 69, no. 1, pp. 139–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. I. J. Benjamin and D. R. McMillan, “Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease,” Circulation Research, vol. 83, no. 2, pp. 117–132, 1998. View at Google Scholar · View at Scopus
  34. S. Mnaimneh, A. P. Davierwala, J. Haynes et al., “Exploration of essential gene functions via titratable promoter alleles,” Cell, vol. 118, no. 1, pp. 31–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Demasi, G. M. Silva, and L. E. S. Netto, “20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated,” Journal of Biological Chemistry, vol. 278, no. 1, pp. 679–685, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. I. Morimoto, “Dynamic remodeling of transcription complexes by molecular chaperones,” Cell, vol. 110, no. 3, pp. 281–284, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Huang, K. Alvares, R. Chu, C. A. Bradfield, and J. K. Reddy, “Association of peroxisome proliferator-activated receptor and Hsp72,” Journal of Biological Chemistry, vol. 269, no. 11, pp. 8493–8497, 1994. View at Google Scholar · View at Scopus
  38. W. K. Sumanasekera, E. S. Tien, J. W. Davis, R. Turpey, G. H. Perdew, and J. P. V. Heuvel, “Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity,” Biochemistry, vol. 42, no. 36, pp. 10726–10735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Blanquart, O. Barbier, J. C. Fruchart, B. Staels, C. Glineur, and I. I. De Université Lille, “Peroxisome proliferator-activated receptor α (PPARα) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37254–37259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Pause, P. Diestelkötter, H. Heid, and W. W. Just, “Cytosolic factors mediate protein insertion into the peroxisomal membrane,” FEBS Letters, vol. 414, no. 1, pp. 95–98, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. D. S. Latchman, “Protection of neuronal and cardiac cells by HSP27,” Progress in Molecular and Subcellular Biology, vol. 28, pp. 253–265, 2002. View at Google Scholar · View at Scopus
  42. H. M. Beere, “Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins,” Science's STKE, vol. 2001, no. 93, p. RE1, 2001. View at Google Scholar · View at Scopus
  43. T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “Critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7473–7478, 1999. View at Publisher · View at Google Scholar
  44. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999. View at Google Scholar · View at Scopus